Trials / Unknown
UnknownNCT04646850
Long-term Treatment With the Ketogenic Diet in Epilepsy
Long-term Treatment With the Ketogenic Diet in Epilepsy and Epilepsy-related Rare Diseases
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study will provide a comprehensive assessment of long-term treatment with the ketogenic diet, a medical diet with high fat and low carbohydrate intake, focusing on safety and cardiovascular implications. We will assess patients with epilepsy or one of two rare metabolic diseases; glucose transporter type 1 deficiency syndrome (GLUT1 DS) or pyruvate dehydrogenase complex deficiency (PDHD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Color duplex ultrasound of the carotid arteries | Examinations carried out according to the American Society of Echocardiography guidelines 25 using a Vivid 7 US instrumentation with a linear M12L probe (14 MHZ; General Electric). |
Timeline
- Start date
- 2018-08-06
- Primary completion
- 2022-12-31
- Completion
- 2025-12-31
- First posted
- 2020-11-30
- Last updated
- 2022-10-21
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT04646850. Inclusion in this directory is not an endorsement.